Initiation of cardioprotective glucose-lowering drugs according to sex and educational level: a Danish nationwide cohort study

被引:0
|
作者
Calderon, E. [1 ,2 ]
Bjerg, L. [1 ,3 ]
Isaksen, A. A. [1 ,3 ]
Sandbaek, A. [1 ,3 ]
Funck, K. L. [1 ]
Grove, E. L. [2 ,4 ]
机构
[1] Aarhus Univ Hosp, Steno Diabet Ctr Aarhus, Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark
[3] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark
[4] Aarhus Univ, Dept Clin Med, Hlth, Aarhus, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
400
引用
收藏
页码:S202 / S202
页数:1
相关论文
共 50 条
  • [21] Hypoglycemia risk with inappropriate dosing of glucose-lowering drugs in patients with chronic kidney disease: a retrospective cohort study
    Li, Yun-Jhe
    Chang, Yuh-Lih
    Chou, Yueh-Ching
    Hsu, Chia-Chen
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [22] Association between Glucose-lowering Treatments and Risk of Diabetic Retinopathy in People with Type 2 Diabetes: A Nationwide Cohort Study
    Jensen, Jakob Hasselstrom
    Vestergaard, Peter
    Jensen, Morten Hasselstrom
    CURRENT DRUG SAFETY, 2024, 19 (02) : 236 - 243
  • [23] Adoption of New Glucose-Lowering Medications in the US-The Case of SGLT2 Inhibitors: Nationwide Cohort Study
    McCoy, Rozalina G.
    Dykhoff, Hayley J.
    Sangaralingham, Lindsey
    Ross, Joseph S.
    Karaca-Mandic, Pinar
    Montori, Victor M.
    Shah, Nilay D.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (12) : 702 - 712
  • [24] Risk of death differs according to type of oral glucose-lowering therapy in patients with diabetes and a previous myocardial infarction: a nationwide study
    Schramm, T. K.
    Gislason, G. H.
    Norgaard, M. L.
    Rasmussen, J. N.
    Folke, F.
    Hansen, M. L.
    Jorgensen, C. H.
    Vaag, A.
    Kober, L.
    Torp-Pedersen, C.
    EUROPEAN HEART JOURNAL, 2009, 30 : 304 - 305
  • [25] Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
    Luis M. Pérez-Belmonte
    José David Torres-Peña
    María D. López-Carmona
    M. Mar. Ayala-Gutiérrez
    Francisco Fuentes-Jiménez
    Lucía Jorge Huerta
    Jaime Alonso Muñoz
    Manuel Rubio-Rivas
    Manel Madrazo
    Marcos Guzmán Garcia
    Beatriz Vicente Montes
    Joaquim Fernández Sola
    Javier Ena
    Ruth Gonzalez Ferrer
    Carmen Mella Pérez
    Carlos Jorge Ripper
    Jose Javier Napal Lecumberri
    Iris El Attar Acedo
    Susana Plaza Canteli
    Sara Fuente Cosío
    Francisco Amorós Martínez
    Begoña Cortés Rodríguez
    Pablo Pérez-Martínez
    José Manuel Ramos-Rincón
    Ricardo Gómez-Huelgas
    BMC Medicine, 18
  • [26] Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
    Perez-Belmonte, Luis M.
    Torres-Pena, Jose David
    Lopez-Carmona, Maria D.
    Ayala-Gutierrez, M. Mar.
    Fuentes-Jimenez, Francisco
    Huerta, Lucia Jorge
    Munoz, Jaime Alonso
    Rubio-Rivas, Manuel
    Madrazo, Manel
    Garcia, Marcos Guzman
    Montes, Beatriz Vicente
    Sola, Joaquim Fernandez
    Ena, Javier
    Ferrer, Ruth Gonzalez
    Perez, Carmen Mella
    Ripper, Carlos Jorge
    Lecumberri, Jose Javier Napal
    Acedo, Iris El Attar
    Canteli, Susana Plaza
    Cosio, Sara Fuente
    Martinez, Francisco Amoros
    Rodriguez, Begona Cortes
    Perez-Martinez, Pablo
    Ramos-Rincon, Jose Manuel
    Gomez-Huelgas, Ricardo
    BMC MEDICINE, 2020, 18 (01)
  • [27] Metformin and other glucose-lowering drug initiation and rates of community-based antibiotic use and hospital-treated infections in patients with type 2 diabetes: a Danish nationwide population-based cohort study
    Mor, Anil
    Petersen, Irene
    Sorensen, Henrik T.
    Thomsen, Reimar W.
    BMJ OPEN, 2016, 6 (08):
  • [28] Metformin and Other Glucose-Lowering Drug Initiation and Rates of Community-Based Antibiotic Use and Hospital-Treated Infections in Patients with Type 2 Diabetes: A Danish Nationwide Population-Based Cohort Study
    Thomsen, Reimar Wernich
    Mor, Anil
    Petersen, Irene
    Sorensen, Henrik Toft
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 544 - 545
  • [29] Statin Treatment Is Insufficient in Diabetes Patients Receiving Glucose-Lowering Treatment: A Nationwide Study
    Dominguez, Helena
    Schramm, Tina K.
    Gislason, Gunnar
    Abildstrom, Steen
    Kober, Lars
    Guterbaum, Thomas J.
    Jorgensen, Casper
    Norgaard, Mette L.
    Torp-Pedersen, Christian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A203 - A203
  • [30] Benefits and Risks of Glucose-Lowering Treatments With Particular Emphasis on Metformin: Nationwide Epidemiological Study
    Ekstrom, Nils
    Schioler, Linus
    Svensson, Ann-Marie
    Eegolofsson, Katarina
    Jonasson, Junmei Miao
    Zethelius, Bjorn
    Cederholm, Jan
    Gudbjornsdottir, Soffia
    Eliasson, Bjorn
    DIABETES, 2012, 61 : A381 - A381